Overview
Global growth in the life sciences sector is no longer just a question of where to expand, but how to do so in a more demanding, less predictable environment. Supply chains, once optimised for efficiency, are now being redesigned for resilience, visibility, and control.
Businesses in the sector are rethinking how products are sourced, manufactured, and distributed to improve resilience, meet regulatory requirements, and ensure consistent access across regions.
Our latest report for pharma and life sciences explores how businesses in the sector are responding to this shift – reshaping where they operate, how they structure their networks, and what capabilities they need to grow sustainability.
Download the report